Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

226 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dual guidance structure for evaluation of patients with unclear diagnosis in centers for rare diseases (ZSE-DUO): study protocol for a controlled multi-center cohort study.
Hebestreit H, Zeidler C, Schippers C, de Zwaan M, Deckert J, Heuschmann P, Krauth C, Bullinger M, Berger A, Berneburg M, Brandstetter L, Deibele A, Dieris-Hirche J, Graessner H, Gündel H, Herpertz S, Heuft G, Lapstich AM, Lücke T, Maisch T, Mundlos C, Petermann-Meyer A, Müller S, Ott S, Pfister L, Quitmann J, Romanos M, Rutsch F, Schaubert K, Schubert K, Schulz JB, Schweiger S, Tüscher O, Ungethüm K, Wagner TOF, Haas K; ZSE-DUO working group. Hebestreit H, et al. Among authors: berneburg m. Orphanet J Rare Dis. 2022 Feb 14;17(1):47. doi: 10.1186/s13023-022-02176-1. Orphanet J Rare Dis. 2022. PMID: 35164804 Free PMC article.
[Light protection for xeroderma pigmentosum].
Ettinger M, Berneburg M. Ettinger M, et al. Among authors: berneburg m. Hautarzt. 2017 May;68(5):359-363. doi: 10.1007/s00105-017-3978-4. Hautarzt. 2017. PMID: 28401271 Review. German.
Active vs. standard sun protection in patients with melanoma stage I or II: a randomized controlled feasibility trial assessing compliance with sun protection and quality of life.
Goeth H, Koller M, Hegemann MV, Drexler K, Zeman F, Huppertz G, Berneburg M, Maisch T. Goeth H, et al. Among authors: berneburg m. Br J Dermatol. 2020 Dec;183(6):1132-1134. doi: 10.1111/bjd.19395. Epub 2020 Sep 11. Br J Dermatol. 2020. PMID: 32652591 Clinical Trial. No abstract available.
TIMolol nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia (HHT) - Study protocol of the prospective, randomized, double-blind, controlled cross-over TIM-HHT trial.
Andorfer KEC, Seebauer CT, Koller M, Zeman F, Berneburg M, Fischer R, Vielsmeier V, Bohr C, Kühnel TS. Andorfer KEC, et al. Among authors: berneburg m. Clin Hemorheol Microcirc. 2022;80(3):307-315. doi: 10.3233/CH-211253. Clin Hemorheol Microcirc. 2022. PMID: 34864649
226 results